Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (6,929,685)	$ (6,063,517)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,541,450	957,871
Depreciation and amortization	22,730	18,143
Change in fair value of contingent consideration	(324,992)	30,000
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	76,304	(1,902,277)
Right of use asset	67,170	0
Operating lease liability	(69,652)	0
Prepaid expenses and other assets	(4,512,635)	(389,468)
Net cash used in operating activities	(10,129,310)	(7,349,248)
Cash flows from investing activities:
Purchase of property and equipment	0	(82,105)
Net cash used in investing activities	0	(82,105)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net of issuance costs	0	82,153,600
Contingent consideration milestone payment	(2,000,000)	0
Net cash provided by financing activities	(2,000,000)	82,153,600
Effect of exchange rates on cash	3,169	0
Net increase in cash	(12,126,141)	74,722,247
Cash at beginning of period	91,348,967	40,726,838
Cash at end of period	79,222,826	115,449,085
Supplementary disclosure of non-cash financing activities:
Conversion of Series C convertible preferred stock	5,000	10,000
Issuance of common stock in conjunction with milestone payment	5,008	0
Fair value of warrants issued to placement agent	0	2,013,055
Adoption of new accounting standard	$ 0	$ 11,672